REVIEW
Published on 16 Apr 2025
Exploration of the role of immune cells and cell therapy in hepatocellular carcinoma
doi 10.3389/fimmu.2025.1569150
- 705 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Exploring the role of immune cells and cell therapy in liver cancer
Exploring the role of immune cells and cell therapy in liver cancer
7,826
Total downloads
24k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 08 Apr 2025
Stimulation of regulatory dendritic cells suppresses cytotoxic T cell function and alleviates DEN-induced liver injury, fibrosis and hepatocellular carcinoma
doi 10.3389/fimmu.2025.1565486
- 1,192 views
ORIGINAL RESEARCH
Published on 20 Feb 2025
Development of a prognostic model for hepatocellular carcinoma based on microvascular invasion characteristic genes by spatial transcriptomics sequencing
doi 10.3389/fimmu.2025.1529569
- 1,452 views
REVIEW
Published on 12 Dec 2024
Targeting caspase-8: a new strategy for combating hepatocellular carcinoma
doi 10.3389/fimmu.2024.1501659
- 2,154 views
- 2 citations
REVIEW
Published on 08 Nov 2024
Models of fibrolamellar carcinomas, tools for evaluation of a new era of treatments
doi 10.3389/fimmu.2024.1459942
- 1,633 views
- 1 citation
MINI REVIEW
Published on 06 Nov 2024
CAR-T cell therapy for hepatocellular carcinoma: current trends and challenges
doi 10.3389/fimmu.2024.1489649
- 3,967 views
- 9 citations
ORIGINAL RESEARCH
Published on 03 Sep 2024
Chemotherapy combined with lenvatinib and PD-1 may be a potential better alternative option for advanced unresectable intrahepatic cholangiocarcinoma: a retrospective real-world study
doi 10.3389/fimmu.2024.1463574
- 1,448 views
- 1 citation
REVIEW
Published on 03 Sep 2024
Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment
doi 10.3389/fimmu.2024.1460282
- 3,500 views
- 7 citations
SYSTEMATIC REVIEW
Published on 30 Aug 2024
Efficacy and safety of transarterial chemoembolization plus lenvatinib combined with PD-1 inhibitors versus transarterial chemoembolization plus lenvatinib for unresectable hepatocellular carcinoma: a meta-analysis
doi 10.3389/fimmu.2024.1466113
- 1,925 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: